Abstract: A new method for recycling polyurethane, in particular polyurethane foam via solvolysis can be performed. The new method includes a very efficient pre-treatment method of the polyurethane, wherein it is converted into a polyurethane dispersion. The method also includes providing the polyurethane, preparing a dispersion, and solvolyzing the dispersion. The polyurethane has an average particle size of 0.1 to 12 mm.

Abstract: The present invention concerns a composition comprising at least one polymer, wherein the polymer solidifies from a molten material in a substantially amorphous or completely amorphous form. The present invention further concerns a process for the production of the composition in accordance with the invention, as well as a structural component comprising a composition in accordance with the invention and the use of the composition in accordance with the invention.

Abstract: The present invention relates to a method for oxidizing manganese species in a treatment device (10) comprising at least one anode unit (20) and at least one cathode (30), wherein said unit comprises at least one anode (21) and is confined by a housing (22), the housing defining a free inner volume (V), wherein (i) the housing comprises at least one permeable barrier (23) and the at least one cathode is located outside the anode unit, or (ii) the at least one anode unit comprises at least partly the at least one cathode, wherein the housing does not comprise a permeable barrier, characterized in that in (i) and (ii) the at least one anode and the at least one cathode have a distance (d) ranging from 0.5 mm to 100 mm. The invention furthermore refers to a respective treatment device (10).

Abstract: The present invention relates to anti-HLA-G antibodies and methods of using the same.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: A method for monitoring an implantable device. The method comprises: receiving at least one cardiac vector signal, wherein the at least one cardiac vector signal is acquired by the implantable device between at least one pair of electrodes; extracting two or more separate features from the at least one cardiac vector signal by signal processing; deriving a hardware status (pnoise) of the implantable device based at least in part on a classification of the extracted two or more separate features.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: A method for operating a hearing device having an input transducer, a signal processing device and an output transducer includes using the input transducer to generate an input signal. The signal processing device has a quality checking unit used to take the input signal as a basis for determining a measure of a signal quality. The quality checking unit is configured for two operating modes, specifically a first operating mode and a second operating mode. The signal processing device has an own voice checking unit used to take the input signal as a basis for determining an activity of an own voice. The quality checking unit is operated in the first operating mode if no activity of an own voice is determined and in the second operating mode if an activity of the own voice is determined. A hearing device and a computer program product perform the method.

Abstract: The disclosure relates, inter alia, to a vehicle headlight (10), for example for a motor vehicle (1), wherein the vehicle headlight (10) comprises an illumination matrix (534) with a plurality of independently controllable illumination pixels for generating a (for example time-variant) illumination pattern, wherein the vehicle headlight (10) comprises an objective for imaging the illumination pattern, and wherein the objective comprises at least one objective lens.

Abstract: The present invention relates to anti-PD1 antibodies and methods of using the same.

Abstract: The present disclosure relates to computer-implemented methods, software, and systems for obtaining incoming alerts associated with tickets generated for health status issues identified by applications for central components of a cloud platform environment. The obtained incoming alerts are aggregated to determine a root cause ticket. A set of incoming alerts is associated with a first central component running at a first data center from one or more data centers of the cloud platform environment. The set of incoming alerts are generated based on a set of tickets logged at a first ticketing system of the first data center by one or more applications running on the first data center. A root cause ticket is generated to combine the set of tickets corresponding to the set of incoming alerts, and the root cause ticket identifies the first central component as associated with a first health status issue.

Abstract: The present invention relates to anti-HLA-G antibodies and methods of using the same.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The disclosure relates, inter alia, to a vehicle headlight (10), for example for a motor vehicle (1), wherein the vehicle headlight (10) comprises an illumination matrix (534) with a plurality of independently controllable illumination pixels for generating a (for example time-variant) illumination pattern, wherein the vehicle headlight (10) comprises an objective for imaging the illumination pattern, and wherein the objective comprises at least one objective lens.

Abstract: The present invention relates to anti-LAG3 antibodies, to methods of producing these molecules and methods of using the same.

Abstract: Herein is reported a co-cultivation system for co-cultivating a pool of rabbit B-cells or single deposited rabbit B-cells wherein cells CD40L expressing CHO cells are used as feeder in the presence of TL-2 and TL-21.

Abstract: The invention provides anti-S-HBs antibodies and methods of using the same.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The present invention relates to anti-PD1 antibodies and methods of using the same.